Abstract
BackgroundBladder cancer is the sixth most common cancer in the world and the incidence is particularly high in southwestern Taiwan. Previous studies have identified several tumor-related genes that are hypermethylated in bladder cancer; however the DNA methylation profile of bladder cancer in Taiwan is not fully understood.MethodsIn this study, we compared the DNA methylation profile of multiple tumor suppressor genes (APC, DAPK, E-cadherin, hMLH1, IRF8, p14, p15, RASSF1A, SFRP1 and SOCS-1) in bladder cancer patients from different Chinese sub-populations including Taiwan (104 cases), Hong Kong (82 cases) and China (24 cases) by MSP. Two normal human urothelium were also included as control. To investigate the diagnostic potential of using DNA methylation in non-invasive detection of bladder cancer, degree of methylation of DAPK, IRF8, p14, RASSF1A and SFRP1 was also accessed by quantitative MSP in urine samples from thirty bladder cancer patients and nineteen non-cancer controls.ResultsThere were distinct DNA methylation epigenotypes among the different sub-populations. Further, samples from Taiwan and China demonstrated a bimodal distribution suggesting that CpG island methylator phentotype (CIMP) is presented in bladder cancer. Moreover, the number of methylated genes in samples from Taiwan and Hong Kong were significantly correlated with histological grade (P < 0.01) and pathological stage (P < 0.01). Regarding the samples from Taiwan, methylation of SFRP1, IRF8, APC and RASSF1A were significantly associated with increased tumor grade, stage. Methylation of RASSF1A was associated with tumor recurrence. Patients with methylation of APC or RASSF1A were also significantly associated with shorter recurrence-free survival. For methylation detection in voided urine samples of cancer patients, the sensitivity and specificity of using any of the methylated genes (IRF8, p14 or sFRP1) by qMSP was 86.7% and 94.7%.ConclusionsOur results indicate that there are distinct methylation epigenotypes among different Chinese sub-populations. These profiles demonstrate gradual increases with cancer progression. Finally, detection of gene methylation in voided urine with these distinct DNA methylation markers is more sensitive than urine cytology.
Highlights
Bladder cancer is the sixth most common cancer in the world and the incidence is high in southwestern Taiwan
Samples from Taiwan showed that frequent methylation was detected in p14 (61.8%), DAPK (51.0%), SFRP1 (47.5%), and IRF8 (46.6%), while methylation was detected in APC (41.4%), hMLH1 (37.5%), RASSF1A (32.7%), p15 (24.5%), SOCS-1 (24.0%), and E-cadherin (21.2%) (Figure 1B)
Distinct DNA methylation epigenotypes in bladder cancer patients from different Chinese sub-populations Compared with different Chinese sub-populations, there were different methylation frequency among samples from Taiwan, Hong Kong and China (Figure 2)
Summary
Bladder cancer is the sixth most common cancer in the world and the incidence is high in southwestern Taiwan. Majority of bladder cancer is comprised of urothelial carcinoma (UC) ( known as transitional cell carcinoma, TCC). The incidence of urothelial cancer is high in southwestern coast of Taiwan [2] suggesting that UC in these areas may have unique carcinogenesis pathway. UC patients will need to have a long-term follow-up with repeated urine cytology and invasive cystoscopy for recurrence monitoring. Conventional urine cytology has been the standard noninvasive method for cancer detection and disease monitoring; the sensitivity of this method is known to be low, especially for low-grade UC. A more sensitive, non-invasive method for cancer detection is required
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
